With a clear role in the regulation of proinflammatory TCR and cytokine signals, TCPTP and PTP1B have become of particular interest in areas where disruption tolerogenic signals is beneficial such as in cancer immunotherapy. This evidence concerns the gene PTPN2 and cancer.